Biocon has informed that it enclosed the press release dated October 08, 2024, titled ‘Biocon Biologics’ Commissioned Report Highlights Pathways to Increase Adoption of Biosimilars in LMICs; GaBI Publishes Peer-Reviewed Article’.
The above information is a part of company’s filings submitted to BSE.